SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 26, Issue 11, 2008, Pages 1899-1900

Compassionate approval process for experimental gene-based products

(3) Wallraven, Gladice a Nemunaitis, John J a Maples, Phillip B b

a Mary Crowley Cancer Research Centers (United States)

b GRADALIS INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVEXIN; GEMCITABINE; TRANSFORMING GROWTH FACTOR BETA2; TUMOR CELL VACCINE; CANCER VACCINE; DEOXYCYTIDINE; DRUG DERIVATIVE; VIRUS VACCINE;

ADULT; AGED; ANAMNESIS; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG APPROVAL; DRUG EFFICACY; EMBRYONAL CARCINOMA; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; LETTER; MALE; PANCREAS CANCER; PRIORITY JOURNAL; EMPATHY; EXPERIMENTAL THERAPY; FOOD AND DRUG ADMINISTRATION; GENE THERAPY; GENE TRANSFER; METHODOLOGY; PANCREAS TUMOR; PSYCHOLOGICAL ASPECT; TERMINAL CARE; TIME; TUMOR SUPPRESSOR GENE; UNITED STATES;

ADULT; AGED; CANCER VACCINES; DEOXYCYTIDINE; DRUG APPROVAL; EMPATHY; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; HUMANS; LI-FRAUMENI SYNDROME; MALE; PANCREATIC NEOPLASMS; TERMINAL CARE; THERAPIES, INVESTIGATIONAL; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VIRAL VACCINES;

EID: 42949094799 PISSN: 0732183X EISSN: None Source Type: Journal
DOI: 10.1200/JCO.2008.16.2156 Document Type: Letter

Times cited : (2)

References (8)

1
- 84871474319
- and
- US Food and Drug Administration: Oncology tools: Access to unapproved drugs. www.fda.gov/cder/cancer/access.htm
- Oncology tools: Access to unapproved drugs
- Food, U.S.¹

2
- 4243587800
- and
- US Food and Drug Administration: Oncology Tools. http://www.fda.gov/cder/ cancer/SingleIND.htm
- Oncology Tools
- Food, U.S.¹

3
- 0012164128
- and, CDER
- US Food and Drug Administration: FDA Forms Distribution Page for Center for Drug Evaluation and Research (CDER). http://www.fda.gov/opacom/morechoices/ fdaforms/cder.html
- FDA Forms Distribution Page for Center for Drug Evaluation and Research
- Food, U.S.¹

4
- 0033649693
- Experimental treatments: Unapproved but not always unavailable
- Thompson L: Experimental treatments: Unapproved but not always unavailable. FDA Consumer Magazine 34:8-13, 2000
- (2000) FDA Consumer Magazine , vol.34 , pp. 8-13
- Thompson, L.¹

5
- 84871468209
- National Institutes of Health notice pertinent to the April 2002 revisions of the NIH guidelines for research involving recombinant DNA molecules. http://www4.od.nih.gov/oba/rac/guidelines_02/Appendix_M.htm
- National Institutes of Health notice pertinent to the April 2002 revisions of the NIH guidelines for research involving recombinant DNA molecules. http://www4.od.nih.gov/oba/rac/guidelines_02/Appendix_M.htm

6
- 0033950285
- Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
- Nemunaitis, J, Swisher SG, Timmons T, et al: Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 18:609-622, 2000
- (2000) J Clin Oncol , vol.18 , pp. 609-622
- Nemunaitis, J.¹ Swisher, S.G.² Timmons, T.³

7
- 34250728105
- p53 therapy in a patient with Li-Fraumeni syndrome
- Senzer N, Nemunaitis J, Nemunaitis M, et al: p53 therapy in a patient with Li-Fraumeni syndrome. Mol Cancer Ther 6:1478-1482, 2007
- (2007) Mol Cancer Ther , vol.6 , pp. 1478-1482
- Senzer, N.¹ Nemunaitis, J.² Nemunaitis, M.³

8
- 33750586798
- Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer
- Nemunaitis J, Dillman RO, Schwarzenberger PO, et al: Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer. J Clin Oncol 24:4721-4730, 2006
- (2006) J Clin Oncol , vol.24 , pp. 4721-4730
- Nemunaitis, J.¹ Dillman, R.O.² Schwarzenberger, P.O.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.